Efficacy+of+Non-Hodgkin's+Lymphoma+Vaccine+Demonstrated+in+Dogs

Developing a vaccine, researchers at UPenn schools of Medicine and Vet Medicine make the first veterinary cancer vaccine that shows survival increase for dogs with non-Hodgkin's lymphoma.

The team of many professors/hematology and oncology professionals contributed to the research, as well as recuiting dogs that were diagnosed with the disease. They received the cell-based vaccine and chemotherapy. They tracked this experiment for several years to see if the vaccine would prolong survival for the furry four-legged creatures. Some of the dogs were not affected like others, but in some dogs, they are still alive and have been cancer free for over three years.

The cell-based vaccine was injected and worked to stimulate the other cells, promoting them to perform apoptosis along with the cancerous cells. Even though this only worked in 40% of the dogs, it can still be improved to become more functional. More trials will need to be done with different varieties of this vaccine.

This topic is relating to our upcoming discussion on cancerous cells, and what can be done to stimulate/make the mitosis process become controlled.

Liz P

[]